FormWeb • carbidopa-entacapone-levodopa

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

carbidopa-entacapone-levodopa

carbidopa-entacapone-levodopa

Formulary

Drug Name	Form	Strength
Stalevo 50	TABLET, ORAL	12.5 mg-200 mg-50 mg
Stalevo 75	TABLET, ORAL	18.75 mg-200 mg-75 mg
Stalevo 100	TABLET, ORAL	25 mg-200 mg-100 mg
Stalevo 125	TABLET, ORAL	31.25 mg-200 mg-125 mg
Stalevo 150	TABLET, ORAL	37.5 mg-200 mg-150 mg
Stalevo 200	TABLET, ORAL	50 mg-200 mg-200 mg

VIEW MORE Central Nervous System Agents, Miscellaneous
CLASS

Comments:

STALEVO tablets should not be split or crushed.

Reviewed: May 23, 2006

Last updated: Dec. 22, 2023

Black Box Warning: Bolded (not boxed): Carbidopa dosing
Formulary, Not Routinely Stocked: 18.75-75-200 mg tablet; 31.25-125-200 mg tablet; 25-100-200 mg tablet

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.